| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | DDX19B DDX19A MYH4 ABCC4 ANXA1 MCM2 CHD7 FANCM BCS1L ABCA9 KIF20B ATAD3B DNAH12 STARD9 KIF2A ATP6V1C2 ASCC3 DNAH5 SNRNP200 | 2.01e-08 | 614 | 131 | 19 | GO:0140657 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | DDX19B DDX19A MYH4 ABCC4 MCM2 CHD7 FANCM BCS1L ABCA9 KIF20B ATAD3B DNAH12 KIF2A ASCC3 DNAH5 SNRNP200 | 3.31e-08 | 441 | 131 | 16 | GO:0016887 |
| GeneOntologyMolecularFunction | helicase activity | 9.77e-06 | 158 | 131 | 8 | GO:0004386 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | DDX19B DDX19A MYH4 ABCC4 MCM2 CHD7 FANCM BCS1L ABCA9 KIF20B SEPTIN6 ATAD3B DNAH12 KIF2A ASCC3 DNAH5 SNRNP200 | 1.29e-05 | 775 | 131 | 17 | GO:0017111 |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | DDX19B DDX19A TENT4B ANXA1 IARS1 POLR2B POLR1C CARS1 MCM2 CHD7 FANCM TEP1 ASCC3 SNRNP200 TRMT12 | 2.21e-05 | 645 | 131 | 15 | GO:0140640 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | DDX19B DDX19A MYH4 ABCC4 MCM2 CHD7 FANCM BCS1L ABCA9 KIF20B SEPTIN6 ATAD3B DNAH12 KIF2A ASCC3 DNAH5 SNRNP200 | 3.53e-05 | 839 | 131 | 17 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | DDX19B DDX19A MYH4 ABCC4 MCM2 CHD7 FANCM BCS1L ABCA9 KIF20B SEPTIN6 ATAD3B DNAH12 KIF2A ASCC3 DNAH5 SNRNP200 | 3.59e-05 | 840 | 131 | 17 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | DDX19B DDX19A MYH4 ABCC4 MCM2 CHD7 FANCM BCS1L ABCA9 KIF20B SEPTIN6 ATAD3B DNAH12 KIF2A ASCC3 DNAH5 SNRNP200 | 3.59e-05 | 840 | 131 | 17 | GO:0016818 |
| GeneOntologyMolecularFunction | microtubule motor activity | 9.68e-05 | 70 | 131 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.28e-04 | 118 | 131 | 6 | GO:0003774 | |
| GeneOntologyMolecularFunction | 3'-5' DNA helicase activity | 1.45e-04 | 16 | 131 | 3 | GO:0043138 | |
| GeneOntologyMolecularFunction | RNA polymerase III type 3 promoter sequence-specific DNA binding | 6.30e-04 | 6 | 131 | 2 | GO:0001006 | |
| GeneOntologyMolecularFunction | DNA helicase activity | 7.35e-04 | 62 | 131 | 4 | GO:0003678 | |
| GeneOntologyMolecularFunction | RNA polymerase III cis-regulatory region sequence-specific DNA binding | 8.78e-04 | 7 | 131 | 2 | GO:0000992 | |
| GeneOntologyMolecularFunction | RNA polymerase III transcription regulatory region sequence-specific DNA binding | 1.17e-03 | 8 | 131 | 2 | GO:0001016 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 1.51e-03 | 127 | 131 | 5 | GO:0008094 | |
| GeneOntologyMolecularFunction | calcium channel activity | 1.62e-03 | 129 | 131 | 5 | GO:0005262 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 1.73e-03 | 262 | 131 | 7 | GO:0140097 | |
| GeneOntologyMolecularFunction | RNA helicase activity | 1.73e-03 | 78 | 131 | 4 | GO:0003724 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on RNA | DDX19B DDX19A IARS1 POLR2B POLR1C CARS1 FANCM SNRNP200 TRMT12 | 1.74e-03 | 417 | 131 | 9 | GO:0140098 |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on RNA | 1.90e-03 | 80 | 131 | 4 | GO:0008186 | |
| GeneOntologyCellularComponent | centriole | 1.12e-04 | 172 | 132 | 7 | GO:0005814 | |
| Domain | P-loop_NTPase | DDX19B DDX19A MYH4 DLG5 ABCC4 MCM2 CHD7 FANCM TEP1 BCS1L ABCA9 KIF20B SEPTIN6 ATAD3B DNAH12 STARD9 CARD11 KIF2A ASCC3 DNAH5 SNRNP200 | 3.96e-07 | 848 | 130 | 21 | IPR027417 |
| Domain | AAA | 7.56e-06 | 144 | 130 | 8 | SM00382 | |
| Domain | AAA+_ATPase | 7.56e-06 | 144 | 130 | 8 | IPR003593 | |
| Domain | - | DDX19B DDX19A DLG5 ABCC4 MCM2 CHD7 FANCM TEP1 BCS1L ABCA9 SEPTIN6 ATAD3B DNAH12 CARD11 ASCC3 DNAH5 SNRNP200 | 1.67e-05 | 746 | 130 | 17 | 3.40.50.300 |
| Domain | Helicase_C | 1.03e-04 | 107 | 130 | 6 | PF00271 | |
| Domain | HELICc | 1.03e-04 | 107 | 130 | 6 | SM00490 | |
| Domain | Helicase_C | 1.08e-04 | 108 | 130 | 6 | IPR001650 | |
| Domain | HELICASE_CTER | 1.14e-04 | 109 | 130 | 6 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 1.14e-04 | 109 | 130 | 6 | PS51192 | |
| Domain | DEXDc | 1.14e-04 | 109 | 130 | 6 | SM00487 | |
| Domain | Helicase_ATP-bd | 1.20e-04 | 110 | 130 | 6 | IPR014001 | |
| Domain | STPPase_N | 1.44e-04 | 3 | 130 | 2 | IPR031675 | |
| Domain | STPPase_N | 1.44e-04 | 3 | 130 | 2 | PF16891 | |
| Domain | DEAD/DEAH_box_helicase_dom | 1.56e-04 | 73 | 130 | 5 | IPR011545 | |
| Domain | DEAD | 1.56e-04 | 73 | 130 | 5 | PF00270 | |
| Domain | Sec63 | 2.86e-04 | 4 | 130 | 2 | PF02889 | |
| Domain | Sec63 | 2.86e-04 | 4 | 130 | 2 | SM00973 | |
| Domain | Sec63-dom | 2.86e-04 | 4 | 130 | 2 | IPR004179 | |
| Domain | TRPM_tetra | 2.86e-04 | 4 | 130 | 2 | PF16519 | |
| Domain | TRPM_tetra | 2.86e-04 | 4 | 130 | 2 | IPR032415 | |
| Domain | SANT | 4.03e-04 | 50 | 130 | 4 | SM00717 | |
| Domain | SANT/Myb | 4.68e-04 | 52 | 130 | 4 | IPR001005 | |
| Domain | tRNA-bd_arm | 5.99e-04 | 24 | 130 | 3 | IPR010978 | |
| Domain | Myb-like_dom | 7.08e-04 | 6 | 130 | 2 | IPR017877 | |
| Domain | CUT | 9.87e-04 | 7 | 130 | 2 | PS51042 | |
| Domain | CUT | 9.87e-04 | 7 | 130 | 2 | PF02376 | |
| Domain | CUT_dom | 9.87e-04 | 7 | 130 | 2 | IPR003350 | |
| Domain | CUT | 9.87e-04 | 7 | 130 | 2 | SM01109 | |
| Domain | HTH_MYB | 1.68e-03 | 9 | 130 | 2 | PS51294 | |
| Domain | Myb_dom | 1.68e-03 | 9 | 130 | 2 | IPR017930 | |
| Domain | Myb_DNA-binding | 1.83e-03 | 35 | 130 | 3 | PF00249 | |
| Domain | - | 1.85e-03 | 321 | 130 | 8 | 3.80.10.10 | |
| Domain | L_dom-like | 2.11e-03 | 328 | 130 | 8 | IPR032675 | |
| Domain | MYB_LIKE | 2.33e-03 | 38 | 130 | 3 | PS50090 | |
| Domain | Kinesin_motor_CS | 2.90e-03 | 41 | 130 | 3 | IPR019821 | |
| Domain | Leu-rich_rpt | 2.91e-03 | 271 | 130 | 7 | IPR001611 | |
| Domain | Rossmann-like_a/b/a_fold | 3.32e-03 | 43 | 130 | 3 | IPR014729 | |
| Domain | - | 3.32e-03 | 43 | 130 | 3 | 3.40.50.620 | |
| Domain | - | 3.54e-03 | 44 | 130 | 3 | 3.40.850.10 | |
| Domain | Kinesin | 3.54e-03 | 44 | 130 | 3 | PF00225 | |
| Domain | KISc | 3.54e-03 | 44 | 130 | 3 | SM00129 | |
| Domain | KINESIN_MOTOR_1 | 3.54e-03 | 44 | 130 | 3 | PS00411 | |
| Domain | Kinesin_motor_dom | 3.54e-03 | 44 | 130 | 3 | IPR001752 | |
| Domain | KINESIN_MOTOR_2 | 3.54e-03 | 44 | 130 | 3 | PS50067 | |
| Domain | ANX | 3.57e-03 | 13 | 130 | 2 | SM00335 | |
| Domain | Annexin_repeat_CS | 3.57e-03 | 13 | 130 | 2 | IPR018252 | |
| Domain | Annexin | 3.57e-03 | 13 | 130 | 2 | PF00191 | |
| Domain | Annexin_repeat | 3.57e-03 | 13 | 130 | 2 | IPR018502 | |
| Domain | PP2Ac | 3.57e-03 | 13 | 130 | 2 | SM00156 | |
| Domain | ANNEXIN | 3.57e-03 | 13 | 130 | 2 | PS00223 | |
| Domain | Ser/Thr-sp_prot-phosphatase | 3.57e-03 | 13 | 130 | 2 | IPR006186 | |
| Domain | - | 3.57e-03 | 13 | 130 | 2 | 1.10.220.10 | |
| Domain | SER_THR_PHOSPHATASE | 3.57e-03 | 13 | 130 | 2 | PS00125 | |
| Domain | Annexin | 4.14e-03 | 14 | 130 | 2 | IPR001464 | |
| Domain | Dynein_heavy_chain_D4_dom | 4.14e-03 | 14 | 130 | 2 | IPR024317 | |
| Domain | Dynein_heavy_dom-2 | 4.14e-03 | 14 | 130 | 2 | IPR013602 | |
| Domain | DHC_N2 | 4.14e-03 | 14 | 130 | 2 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 4.14e-03 | 14 | 130 | 2 | IPR011704 | |
| Domain | AAA_8 | 4.14e-03 | 14 | 130 | 2 | PF12780 | |
| Domain | AAA_5 | 4.14e-03 | 14 | 130 | 2 | PF07728 | |
| Domain | DHC_fam | 4.76e-03 | 15 | 130 | 2 | IPR026983 | |
| Domain | Dynein_heavy | 4.76e-03 | 15 | 130 | 2 | PF03028 | |
| Domain | Dynein_heavy_dom | 4.76e-03 | 15 | 130 | 2 | IPR004273 | |
| Domain | tRNAsynth_Ia_anticodon-bd | 4.76e-03 | 15 | 130 | 2 | IPR009080 | |
| Domain | aa-tRNA-synth_I_CS | 6.84e-03 | 18 | 130 | 2 | IPR001412 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | DDX19B VIM DDX19A ILK IARS1 LRSAM1 POLR2B KTN1 POLR1C CARS1 LAMB1 MCM2 SCRN1 NIBAN2 IPO4 PPP1CA SPDL1 PPP1CC PPP1R7 MTOR EIF2S1 RABEP1 APPL1 EIF3A SNRNP200 CAP1 | 4.69e-11 | 1455 | 133 | 26 | 22863883 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | VIM DDX19A ILK DSP ANXA1 IARS1 LRSAM1 POLR2B KTN1 POLR1C MCM2 CHD7 IPO4 KIF20B PPP1CA PPP1CC NCOR2 EIF2S1 KIF2A EIF3A ASCC3 SNRNP200 CAP1 | 1.86e-09 | 1353 | 133 | 23 | 29467282 |
| Pubmed | VIM EVL HTRA1 VWF DSP ANXA1 IARS1 KTN1 TMOD2 SCRN1 SEPTIN6 PPP1CA PPP1CC PPP1R7 ATAD3B PTPRS EIF2S1 MAP7D2 KIF2A EIF3A VPS51 SNRNP200 CAP1 | 5.35e-09 | 1431 | 133 | 23 | 37142655 | |
| Pubmed | VIM ANXA1 IARS1 POLR2B KTN1 LAMB1 MCM2 SEPTIN6 NCOR2 MTOR EIF2S1 EIF3A SNRNP200 CAP1 | 2.16e-08 | 538 | 133 | 14 | 28524877 | |
| Pubmed | DDX19B FNBP1 EVL ILK ANXA1 IARS1 NAB2 ZMYND8 CHD7 SEPTIN6 MED24 NCOR2 EIF2S1 KIF2A SNRNP200 EP300 CSTF2T CUX1 CAP1 | 4.53e-08 | 1103 | 133 | 19 | 34189442 | |
| Pubmed | DLG5 POLR2B KTN1 POLR1C LAMB1 NIBAN2 IPO4 BCS1L SNX29 BRAP PPP1CC ATAD3B EIF2S1 SYNE2 TMEM209 MAP7D2 PLEKHA1 MRPL40 ASCC3 SNRNP200 CUX1 NIN | 5.19e-08 | 1487 | 133 | 22 | 33957083 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | DDX19B MYH4 CEP85L ANXA1 IARS1 KTN1 POLR1C MCM2 NIBAN2 IPO4 RNF114 PABIR2 ATAD3B MRPL40 EIF3A ASCC3 SNRNP200 NIN | 5.93e-08 | 1005 | 133 | 18 | 19615732 |
| Pubmed | VWF ILK DSP KTN1 LAMA4 RYR1 PPP1CC PPP1R7 KLF10 RABEP1 SYNE2 APPL1 EIF3A | 6.67e-08 | 497 | 133 | 13 | 23414517 | |
| Pubmed | VIM FNBP1 DSP IARS1 KTN1 ZMYND8 KIF20B PPP1CC ATAD3B EIF2S1 MAP7D2 KIF2A EIF3A EEA1 ASCC3 SNRNP200 | 9.05e-08 | 809 | 133 | 16 | 32129710 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | VIM DDX19A TENT4B DSP IARS1 POLR2B KTN1 CARS1 MCM2 IPO4 PPP1CA SPDL1 MTOR EIF2S1 STARD9 KIF2A EIF3A EEA1 DNAH5 SNRNP200 CAP1 | 1.16e-07 | 1425 | 133 | 21 | 30948266 |
| Pubmed | 1.50e-07 | 214 | 133 | 9 | 22199357 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | MYH4 DSP IARS1 KTN1 PIDD1 PARP14 PCDH17 RYR1 MIPOL1 IGSF10 PPP1R7 TRPM3 PKD1 EIF3A SNRNP200 | 1.60e-07 | 736 | 133 | 15 | 29676528 |
| Pubmed | VIM IARS1 POLR2B MCM2 IPO4 PPP1CC MTOR EIF2S1 APPL1 KIF2A EIF3A ASCC3 SNRNP200 CAP1 | 1.75e-07 | 638 | 133 | 14 | 33239621 | |
| Pubmed | VIM DSP POLR2B KTN1 BRAP PPP1CA SPDL1 RABEP1 ASCC3 SNRNP200 EP300 CSTF2T CUX1 | 2.09e-07 | 549 | 133 | 13 | 38280479 | |
| Pubmed | 2.18e-07 | 4 | 133 | 3 | 22211741 | ||
| Pubmed | 2.18e-07 | 4 | 133 | 3 | 12226088 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | FNBP1 EVL SPATA19 JADE3 DSP ZMYND8 MCM2 CHD7 NIBAN2 MED24 NCOR2 APPL1 SNAPC4 SNRNP200 CSTF2T | 3.04e-07 | 774 | 133 | 15 | 15302935 |
| Pubmed | A directed protein interaction network for investigating intracellular signal transduction. | VIM RIN3 ILK ANXA1 ANXA4 ZMYND8 RNF114 BCS1L SEPTIN6 MED24 PPP1R7 KLF10 MTOR SYNE2 FES CARD11 SNAPC4 VPS51 | 3.09e-07 | 1124 | 133 | 18 | 21900206 |
| Pubmed | VIM EVL DSP ANXA1 IARS1 KTN1 SCRN1 KCNB2 SEPTIN6 PPP1CA PPP1CC ATAD3B RABEP1 MAP7D2 APPL1 KIF2A VPS51 CAP1 | 3.75e-07 | 1139 | 133 | 18 | 36417873 | |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | DDX19B VIM ILK IARS1 POLR1C PPP1CC ATAD3B EIF2S1 KIF2A EIF3A ASCC3 SNRNP200 | 4.03e-07 | 486 | 133 | 12 | 30940648 |
| Pubmed | DMTF1 HTRA1 VWF ZMYND8 LAMA4 NIBAN2 PPP1CA PPP1CC NCOR2 UBXN11 KLF10 PKD1 ASCC3 | 4.80e-07 | 591 | 133 | 13 | 15231748 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | VIM DSP ANXA1 IARS1 ANXA4 KTN1 NIBAN2 IPO4 SEPTIN6 RYR1 PPP1CA EIF3A EEA1 SNRNP200 CAP1 | 5.14e-07 | 807 | 133 | 15 | 30575818 |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | VIM ILK ANXA1 KTN1 CARS1 TMOD2 MCM2 IPO4 EIF2S1 SYNE2 KIF2A CAP1 | 5.22e-07 | 498 | 133 | 12 | 36634849 |
| Pubmed | 5.44e-07 | 5 | 133 | 3 | 22801782 | ||
| Pubmed | VIM DSP ZMYND8 CHD7 KIF20B SPDL1 NCOR2 RABEP1 ASCC3 CSTF2T CUX1 | 6.74e-07 | 418 | 133 | 11 | 34709266 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | SEL1L IARS1 POLR2B KTN1 POLR1C ARFGEF1 IPO4 MED24 ATAD3B MTOR EIF2S1 RABEP1 TMEM209 ASCC3 VPS51 CEP97 | 6.89e-07 | 942 | 133 | 16 | 31073040 |
| Pubmed | VIM KTN1 CHD7 IPO4 PPP1CA PPP1CC PPP1R7 NCOR2 PTPRS MTOR RABEP1 SYNE2 APPL1 KIF2A CABIN1 CUX1 | 9.18e-07 | 963 | 133 | 16 | 28671696 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | VIM DLG5 ILK DSP ANXA1 IARS1 ANXA4 KTN1 NAB2 POLR1C ARFGEF1 NIBAN2 IPO4 PLBD2 BRAP NCOR2 MTOR SYNE2 EIF3A | 1.19e-06 | 1367 | 133 | 19 | 32687490 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | VIM TENT4B DSP ANXA1 POLR1C MCM2 IPO4 KIF20B PPP1CC NCOR2 KLF10 EIF2S1 KIF2A EIF3A ATP6V1C2 SNRNP200 | 1.30e-06 | 989 | 133 | 16 | 36424410 |
| Pubmed | DDX19B VIM DLG5 IARS1 MATN2 POLR2B KTN1 POLR1C LAMB1 BRAP PPP1CA PPP1CC NCOR2 EIF2S1 KIF2A ASCC3 CUX1 CAP1 | 1.37e-06 | 1247 | 133 | 18 | 27684187 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | DLG5 TENT4B DSP ANXA1 IARS1 POLR2B POLR1C IPO4 KIF20B PPP1CA PPP1CC FZR1 ATAD3B EIF2S1 KIF2A EIF3A ASCC3 SNRNP200 | 1.53e-06 | 1257 | 133 | 18 | 36526897 |
| Pubmed | 1.89e-06 | 7 | 133 | 3 | 33058883 | ||
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | DDX19B MYH4 ILK DSP ANXA1 IARS1 POLR2B POLR1C IPO4 SEPTIN6 PPP1R7 ATAD3B PTPRS EIF2S1 RABEP1 FES EIF3A SNRNP200 | 2.07e-06 | 1284 | 133 | 18 | 17353931 |
| Pubmed | VIM VWF DSP CEP85L LRSAM1 ZMYND8 POLR1C LAMB1 MIPOL1 TMEM168 RABEP1 PKD1 APPL1 CABIN1 SNRNP200 TRIM37 EP300 CUX1 | 2.09e-06 | 1285 | 133 | 18 | 35914814 | |
| Pubmed | 2.24e-06 | 220 | 133 | 8 | 24550385 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | VIM JADE3 DSP POLR2B KTN1 ZMYND8 POLR1C CHD7 FANCM PPP1CA PPP1CC NCOR2 TMEM209 CABIN1 SNRNP200 EP300 CUX1 MXI1 | 2.30e-06 | 1294 | 133 | 18 | 30804502 |
| Pubmed | SEL1L POLR2B KTN1 POLR1C LAMB1 MCM2 IPO4 PPP1CA PPP1CC ATAD3B MTOR EIF2S1 SYNE2 TMEM209 EIF3A ASCC3 CABIN1 SNRNP200 CUX1 | 2.54e-06 | 1440 | 133 | 19 | 30833792 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | DDX19B DDX19A POLR2B ZMYND8 POLR1C MCM2 IPO4 PPP1CC MTOR EIF2S1 ASCC3 DNAH5 SNRNP200 | 3.31e-06 | 704 | 133 | 13 | 29955894 |
| Pubmed | 3.40e-06 | 399 | 133 | 10 | 37536630 | ||
| Pubmed | VIM LRSAM1 RNF114 PLBD2 PABIR2 BRAP PPP1R7 NCOR2 RABEP1 APPL1 MRPL40 ASCC3 | 3.85e-06 | 604 | 133 | 12 | 38803224 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | VIM DSP IARS1 ZMYND8 PPP1CA PPP1CC ATAD3B EIF2S1 EIF3A ASCC3 SNRNP200 CUX1 | 3.91e-06 | 605 | 133 | 12 | 28977666 |
| Pubmed | ABCC4 DSP ANXA4 PIDD1 NIBAN2 PLBD2 PABIR2 NCOR2 TMEM168 PTPRS PKD1 PLEKHA1 MRPL40 ASCC3 TRIM37 EP300 PRODH | 4.18e-06 | 1215 | 133 | 17 | 15146197 | |
| Pubmed | SEL1L VIM ILK IARS1 POLR2B LAMB1 PLBD2 PPP1CC ATAD3B PTPRS EIF3A SNRNP200 | 4.47e-06 | 613 | 133 | 12 | 22268729 | |
| Pubmed | Cellular substrates and pro-apoptotic function of the human HtrA4 protease. | 4.90e-06 | 173 | 133 | 7 | 31470122 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | DLG5 JADE3 DSP CEP85L POLR2B POLR1C SEPTIN6 MIPOL1 PPP1R7 TMEM209 MAP7D2 TRIM37 CEP97 NIN | 5.30e-06 | 853 | 133 | 14 | 28718761 |
| Pubmed | Lysosomal Signaling Licenses Embryonic Stem Cell Differentiation via Inactivation of Tfe3. | 5.70e-06 | 332 | 133 | 9 | 30595499 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DDX19B VIM DLG5 ILK DSP CEP85L PABIR2 PPP1CA MTOR STARD9 RABEP1 SYNE2 PLEKHA1 KIF2A | 5.89e-06 | 861 | 133 | 14 | 36931259 |
| Pubmed | Identification and characterization of a novel human PP1 phosphatase complex. | 5.94e-06 | 31 | 133 | 4 | 20516061 | |
| Pubmed | Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation. | 6.36e-06 | 180 | 133 | 7 | 30110629 | |
| Pubmed | 6.48e-06 | 118 | 133 | 6 | 21078624 | ||
| Pubmed | DDX19B FNBP1 KTN1 FBF1 CHD7 RYR1 NCOR2 ATAD3B DNAH12 SYNE2 EP300 CUX1 | 6.69e-06 | 638 | 133 | 12 | 31182584 | |
| Pubmed | SEL1L DSP IARS1 ANXA4 POLR2B LAMB1 SEPTIN6 PPP1CC MED24 NCOR2 SYNE2 SNRNP200 EP300 | 6.93e-06 | 754 | 133 | 13 | 35906200 | |
| Pubmed | Cenpj Regulates Cilia Disassembly and Neurogenesis in the Developing Mouse Cortex. | 7.67e-06 | 33 | 133 | 4 | 30626697 | |
| Pubmed | 8.16e-06 | 187 | 133 | 7 | 26460568 | ||
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | DDX19B CUX2 VWF DSP ANXA1 ANXA4 NIBAN2 RYR1 PPP1R7 PKD1 PLEKHA1 APPL1 ATP6V1C2 EEA1 CAP1 | 8.52e-06 | 1016 | 133 | 15 | 19056867 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | VIM DSP ANXA1 IARS1 POLR2B MCM2 IPO4 PABIR2 PPP1CA PPP1R7 EIF2S1 EIF3A EEA1 ASCC3 SNRNP200 CAP1 | 8.69e-06 | 1149 | 133 | 16 | 35446349 |
| Pubmed | VIM EVL MYH4 CUX2 DSP TTC16 KTN1 FBF1 PPP1CA PPP1CC MIPOL1 ATAD3B STARD9 SYNE2 MAP7D2 EIF3A EEA1 CUX1 | 1.02e-05 | 1442 | 133 | 18 | 35575683 | |
| Pubmed | Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration. | VIM HTRA1 SCRN1 BCS1L SEPTIN6 PPP1CA PPP1CC RABEP1 MRPL40 EIF3A CAP1 | 1.06e-05 | 558 | 133 | 11 | 35063084 |
| Pubmed | 1.18e-05 | 131 | 133 | 6 | 28634551 | ||
| Pubmed | Cell-Type-Specific Alternative Splicing Governs Cell Fate in the Developing Cerebral Cortex. | 1.22e-05 | 37 | 133 | 4 | 27565344 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | VIM IARS1 KTN1 MCM2 IPO4 PABIR2 PPP1CA PPP1CC MIPOL1 PPP1R7 MTOR RABEP1 APPL1 EEA1 VPS51 SNRNP200 CEP97 | 1.24e-05 | 1321 | 133 | 17 | 27173435 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 1.35e-05 | 202 | 133 | 7 | 33005030 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 1.40e-05 | 135 | 133 | 6 | 28675934 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 25059644 | ||
| Pubmed | Regulation of mTOR by polycystin-1: is polycystic kidney disease a case of futile repair? | 1.45e-05 | 2 | 133 | 2 | 17102641 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 17646580 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 35581205 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 24642750 | ||
| Pubmed | SDS22 selectively recognizes and traps metal-deficient inactive PP1. | 1.45e-05 | 2 | 133 | 2 | 31548429 | |
| Pubmed | Protein kinase D promotes activity-dependent AMPA receptor endocytosis in hippocampal neurons. | 1.45e-05 | 2 | 133 | 2 | 34564930 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 31848319 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 24204783 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 9882500 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 21278253 | ||
| Pubmed | Cux-1 and Cux-2 control the development of Reelin expressing cortical interneurons. | 1.45e-05 | 2 | 133 | 2 | 18327765 | |
| Pubmed | A unique variant of a homeobox gene related to Drosophila cut is expressed in mouse testis. | 1.45e-05 | 2 | 133 | 2 | 8879483 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 20602103 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 27134121 | ||
| Pubmed | PP-1α and PP-1γ display antagonism and differential roles in tumorigenicity of lung cancer cells. | 1.45e-05 | 2 | 133 | 2 | 23176181 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 34348992 | ||
| Pubmed | ANXA4 Activates JAK-STAT3 Signaling by Interacting with ANXA1 in Basal-Like Breast Cancer. | 1.45e-05 | 2 | 133 | 2 | 32552056 | |
| Pubmed | Expression of a cut-related homeobox gene in developing and polycystic mouse kidney. | 1.45e-05 | 2 | 133 | 2 | 8840273 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 26804994 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 30699353 | ||
| Pubmed | EP300 through upregulating the expression of vimentin to promote the progression of chordoma. | 1.45e-05 | 2 | 133 | 2 | 38691868 | |
| Pubmed | 1.52e-05 | 13 | 133 | 3 | 36350252 | ||
| Pubmed | 1.52e-05 | 13 | 133 | 3 | 24173802 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | DDX19B VIM DDX19A ILK DSP CHD7 NIBAN2 PPP1CA NCOR2 VPS51 SNRNP200 | 1.57e-05 | 582 | 133 | 11 | 20467437 |
| Pubmed | 1.68e-05 | 209 | 133 | 7 | 36779422 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | DLG5 DSP LRSAM1 CHD7 IPO4 KIF20B BRAP NCOR2 RABEP1 TRIM37 NIN | 1.73e-05 | 588 | 133 | 11 | 38580884 |
| Pubmed | VIM ILK ANXA1 IARS1 POLR1C MCM2 IPO4 PPP1CA EIF2S1 EIF3A SNRNP200 CAP1 | 1.85e-05 | 707 | 133 | 12 | 19738201 | |
| Pubmed | 1.93e-05 | 14 | 133 | 3 | 23577725 | ||
| Pubmed | FNBP1 MYH4 IARS1 CARS1 TMOD2 SCRN1 TEP1 SPDL1 ATAD3B MTOR PLEKHA1 PLAC9 ASCC3 | 1.96e-05 | 832 | 133 | 13 | 36724073 | |
| Pubmed | 2.06e-05 | 491 | 133 | 10 | 36273042 | ||
| Pubmed | KTN1 FANCM SEPTIN6 ATAD3B TRPM3 APPL1 ARHGAP28 EIF3A SNRNP200 CSTF2T | 2.13e-05 | 493 | 133 | 10 | 15368895 | |
| Pubmed | DSP ANXA1 IARS1 ARFGEF1 MCM2 KIF20B EIF2S1 EIF3A SNRNP200 CAP1 | 2.17e-05 | 494 | 133 | 10 | 26831064 | |
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | 2.27e-05 | 219 | 133 | 7 | 31353912 | |
| Pubmed | DDX19B DDX19A POLR2B IPO4 BCS1L PLBD2 PPP1CA PPP1CC MTOR KIF2A VPS51 | 2.28e-05 | 606 | 133 | 11 | 36538041 | |
| Pubmed | TENT4B IARS1 KTN1 ZMYND8 POLR1C MCM2 NIBAN2 PPP1CC ATAD3B EIF2S1 EIF3A SNRNP200 CUX1 | 2.36e-05 | 847 | 133 | 13 | 35850772 | |
| Pubmed | 2.37e-05 | 304 | 133 | 8 | 32235678 | ||
| Interaction | VCP interactions | SEL1L VIM FNBP1 RIN3 DSP IARS1 POLR2B FBF1 POLR1C MCM2 NIBAN2 IPO4 BCS1L PLBD2 PPP1CA PPP1CC PPP1R7 ATAD3B UBXN11 MTOR EIF2S1 APPL1 EIF3A EEA1 EP300 CAP1 | 1.81e-06 | 1435 | 132 | 26 | int:VCP |
| Interaction | HDAC1 interactions | VIM FNBP1 MYH4 SMYD1 ZMYND8 ARFGEF1 KIF20B PPP1CA SPDL1 PPP1CC NCOR2 FZR1 RABEP1 SYNE2 APPL1 KIF2A ASCC3 CABIN1 EP300 CSTF2T CUX1 MXI1 | 2.98e-06 | 1108 | 132 | 22 | int:HDAC1 |
| Interaction | CEP128 interactions | VIM DLG5 DSP CEP85L ANXA1 FBF1 MIPOL1 ASCC3 TRIM37 CEP97 NIN | 4.22e-06 | 297 | 132 | 11 | int:CEP128 |
| Interaction | MYPN interactions | 6.12e-06 | 40 | 132 | 5 | int:MYPN | |
| Interaction | PPP1R15A interactions | 6.12e-06 | 40 | 132 | 5 | int:PPP1R15A | |
| Interaction | KRT8 interactions | SEL1L VIM DLG5 DSP ANXA1 ARFGEF1 FZR1 RABEP1 PKD1 TRIM37 CEP97 CUX1 NIN | 6.72e-06 | 441 | 132 | 13 | int:KRT8 |
| Interaction | NINL interactions | DLG5 CCDC146 JADE3 DSP ANXA1 LRSAM1 PPP1CA MIPOL1 FZR1 ATAD3B TRIM37 CEP97 CAP1 | 1.01e-05 | 458 | 132 | 13 | int:NINL |
| Interaction | NPM1 interactions | VIM RIN3 TENT4B JADE3 DSP IARS1 MATN2 KTN1 ZMYND8 POLR1C MCM2 SPDL1 PPP1CC IGSF10 FZR1 EIF2S1 SYNE2 EIF3A ASCC3 SNRNP200 TRIM37 EP300 | 1.08e-05 | 1201 | 132 | 22 | int:NPM1 |
| Interaction | UBR5 interactions | VIM MYH4 ILK DSP MCM2 PPP1CA SPDL1 PPP1CC FZR1 MTOR KIF2A SNRNP200 TRIM37 MXI1 | 1.09e-05 | 533 | 132 | 14 | int:UBR5 |
| Interaction | KCTD13 interactions | VIM EVL HTRA1 VWF DSP ANXA1 IARS1 KTN1 POLR1C TMOD2 SCRN1 SEPTIN6 PPP1CA PPP1CC PPP1R7 PTPRS EIF2S1 MAP7D2 KIF2A EIF3A VPS51 SNRNP200 CEP97 CAP1 | 1.14e-05 | 1394 | 132 | 24 | int:KCTD13 |
| Interaction | RUVBL2 interactions | FNBP1 RIN3 ILK POLR2B POLR1C TMOD2 IPO4 PPP1CA PPP1CC FZR1 MTOR APPL1 KIF2A SNRNP200 EP300 | 1.27e-05 | 616 | 132 | 15 | int:RUVBL2 |
| Interaction | NUP62 interactions | DDX19B DDX19A CCDC146 CEP85L ARFGEF1 MCM2 SYNE2 VPS51 CUX1 NIN | 1.29e-05 | 273 | 132 | 10 | int:NUP62 |
| Interaction | KPNB1 interactions | VIM ILK POLR1C MCM2 IPO4 KIF20B PPP1CA SPDL1 PPP1CC MED24 FZR1 TMEM209 SNRNP200 EP300 | 1.37e-05 | 544 | 132 | 14 | int:KPNB1 |
| Interaction | YWHAZ interactions | VIM EVL DLG5 RIN3 CEP85L ANXA1 SPEG MCM2 PABIR2 PPP1CA PPP1CC FZR1 MTOR STARD9 RABEP1 SYNE2 PLEKHA1 APPL1 KIF2A EIF3A TRIM37 EP300 NIN | 1.46e-05 | 1319 | 132 | 23 | int:YWHAZ |
| Interaction | GSK3B interactions | VIM DLG5 ILK ANXA1 NIBAN2 RNF114 SNX29 PPP1CA PPP1CC MED24 MTOR RABEP1 EIF3A ASCC3 VPS51 CEP97 CAP1 NIN | 1.47e-05 | 868 | 132 | 18 | int:GSK3B |
| Interaction | CCDC85C interactions | 1.85e-05 | 125 | 132 | 7 | int:CCDC85C | |
| Interaction | BRD7 interactions | DDX19B VIM ILK IARS1 POLR1C LAMA4 CHD7 PPP1CC ATAD3B EIF2S1 KIF2A EIF3A ASCC3 SNRNP200 EP300 | 1.88e-05 | 637 | 132 | 15 | int:BRD7 |
| Interaction | ATG16L1 interactions | EVL DLG5 SPEG POLR2B KTN1 CARS1 IPO4 PARP14 SNX29 PPP1CA PPP1CC MED24 RABEP1 PKD1 EIF3A ASCC3 SNAPC4 VPS51 TRIM37 CEP97 CSTF2T | 2.12e-05 | 1161 | 132 | 21 | int:ATG16L1 |
| Interaction | COL1A1 interactions | 2.16e-05 | 128 | 132 | 7 | int:COL1A1 | |
| Interaction | ANAPC2 interactions | 2.42e-05 | 234 | 132 | 9 | int:ANAPC2 | |
| Interaction | PLEC interactions | DDX19B VIM RIN3 MCM2 FANCM SPDL1 PPP1CC RABEP1 SYNE2 FES DNAH5 TRIM37 | 2.65e-05 | 430 | 132 | 12 | int:PLEC |
| Interaction | TRIM52 interactions | 2.76e-05 | 133 | 132 | 7 | int:TRIM52 | |
| Interaction | TP53BP2 interactions | 3.05e-05 | 241 | 132 | 9 | int:TP53BP2 | |
| Interaction | SNW1 interactions | DDX19B VIM DDX19A ILK DSP CHD7 NIBAN2 PPP1CA PPP1CC NCOR2 RABEP1 SNRNP200 TRIM37 EP300 CAP1 NIN | 3.10e-05 | 747 | 132 | 16 | int:SNW1 |
| Interaction | PTGES3 interactions | RIN3 ILK POLR2B POLR1C PIDD1 MCM2 CHD7 TEP1 FZR1 FES ASCC3 SNRNP200 | 3.10e-05 | 437 | 132 | 12 | int:PTGES3 |
| Interaction | ACTA1 interactions | VIM ANXA1 LRSAM1 MCM2 SCRN1 PPP1CA PPP1R7 MRPL40 TRIM37 EP300 CAP1 | 3.37e-05 | 371 | 132 | 11 | int:ACTA1 |
| Interaction | CHD3 interactions | VIM DSP IARS1 NAB2 ZMYND8 MCM2 PPP1CA PPP1CC ATAD3B PTPRS EIF2S1 EIF3A ASCC3 SNRNP200 EP300 CUX1 | 3.64e-05 | 757 | 132 | 16 | int:CHD3 |
| Interaction | LGALS7 interactions | 3.67e-05 | 139 | 132 | 7 | int:LGALS7 | |
| Interaction | ASF1A interactions | 3.94e-05 | 249 | 132 | 9 | int:ASF1A | |
| Interaction | MEN1 interactions | VIM TENT4B ANXA1 IARS1 POLR2B KTN1 ZMYND8 POLR1C ARFGEF1 MCM2 NIBAN2 PARP14 MED24 ATAD3B EIF2S1 EIF3A SNRNP200 CUX1 NIN | 4.14e-05 | 1029 | 132 | 19 | int:MEN1 |
| Interaction | BET1 interactions | DDX19A IARS1 ARFGEF1 KCNB2 ATAD3B EIF2S1 RABEP1 APPL1 EEA1 VPS51 CUX1 | 4.71e-05 | 385 | 132 | 11 | int:BET1 |
| Interaction | LAMP2 interactions | DDX19B KTN1 ARFGEF1 NIBAN2 KCNB2 SNX29 FZR1 MTOR SYNE2 TMEM209 PLEKHA1 EEA1 VPS51 EP300 | 4.71e-05 | 609 | 132 | 14 | int:LAMP2 |
| Interaction | DDB1 interactions | RIN3 ILK ANXA1 POLR2B ZMYND8 PIDD1 BRAP PPP1CA SPDL1 MED24 FZR1 MTOR EIF3A SNRNP200 EP300 | 5.29e-05 | 697 | 132 | 15 | int:DDB1 |
| Interaction | EEF1G interactions | RIN3 ENOX1 KTN1 CARS1 MCM2 IPO4 KIF20B FZR1 PTPRS SNRNP200 TRIM37 EP300 | 5.43e-05 | 463 | 132 | 12 | int:EEF1G |
| Interaction | CLOCK interactions | 5.67e-05 | 102 | 132 | 6 | int:CLOCK | |
| Interaction | RAB5A interactions | DDX19B RIN3 KTN1 NIBAN2 ST14 SNX29 FZR1 RABEP1 SYNE2 TMEM209 PLEKHA1 APPL1 EIF3A EEA1 VPS51 | 6.11e-05 | 706 | 132 | 15 | int:RAB5A |
| Interaction | PPP1R3A interactions | 6.73e-05 | 65 | 132 | 5 | int:PPP1R3A | |
| Interaction | LMTK2 interactions | 7.03e-05 | 106 | 132 | 6 | int:LMTK2 | |
| Interaction | MAT2B interactions | 7.80e-05 | 108 | 132 | 6 | int:MAT2B | |
| Interaction | WDR82 interactions | 8.19e-05 | 213 | 132 | 8 | int:WDR82 | |
| Interaction | ATXN7 interactions | 8.21e-05 | 109 | 132 | 6 | int:ATXN7 | |
| Interaction | PDRG1 interactions | 8.21e-05 | 109 | 132 | 6 | int:PDRG1 | |
| Interaction | AR interactions | DDX19A DSP IARS1 ZMYND8 MCM2 CHD7 IPO4 PPP1CA MED24 NCOR2 FZR1 EIF2S1 FES APPL1 VPS51 SNRNP200 EP300 CUX1 | 8.40e-05 | 992 | 132 | 18 | int:AR |
| Interaction | RPAP2 interactions | 8.61e-05 | 159 | 132 | 7 | int:RPAP2 | |
| Interaction | CDC14A interactions | 9.09e-05 | 111 | 132 | 6 | int:CDC14A | |
| Interaction | TFE3 interactions | 9.12e-05 | 344 | 132 | 10 | int:TFE3 | |
| Interaction | TERF1 interactions | 9.79e-05 | 347 | 132 | 10 | int:TERF1 | |
| Interaction | PHACTR3 interactions | 9.82e-05 | 37 | 132 | 4 | int:PHACTR3 | |
| Interaction | KRT18 interactions | VIM DLG5 CCDC146 DSP MCM2 PPP1CC PKD1 TRIM37 CEP97 EP300 NIN | 1.00e-04 | 419 | 132 | 11 | int:KRT18 |
| Interaction | CEP170P1 interactions | 1.00e-04 | 113 | 132 | 6 | int:CEP170P1 | |
| Interaction | RCOR1 interactions | FNBP1 DSP ZMYND8 CHD7 KIF20B SPDL1 NCOR2 RABEP1 ASCC3 VPS51 CSTF2T CUX1 | 1.00e-04 | 494 | 132 | 12 | int:RCOR1 |
| Interaction | MCM5 interactions | VIM DSP POLR2B MCM2 PPP1CA PPP1R7 FZR1 KIF2A SNRNP200 EP300 CAP1 | 1.02e-04 | 420 | 132 | 11 | int:MCM5 |
| Interaction | CCND1 interactions | 1.14e-04 | 286 | 132 | 9 | int:CCND1 | |
| Interaction | RPAP3 interactions | 1.20e-04 | 225 | 132 | 8 | int:RPAP3 | |
| Interaction | PTEN interactions | FNBP1 DSP ANXA4 POLR2B MCM2 IPO4 KCNB2 PPP1CA IGSF10 NCOR2 FZR1 MTOR PLEKHA1 ASCC3 SNRNP200 TRIM37 CEP97 | 1.21e-04 | 929 | 132 | 17 | int:PTEN |
| Interaction | HSPA1L interactions | 1.23e-04 | 289 | 132 | 9 | int:HSPA1L | |
| Interaction | FBXW7 interactions | ILK ANXA1 IARS1 POLR2B KTN1 ZMYND8 POLR1C MCM2 IPO4 SPDL1 PPP1CC MED24 FZR1 KLF10 MTOR EIF2S1 EIF3A EEA1 ASCC3 SNRNP200 | 1.25e-04 | 1215 | 132 | 20 | int:FBXW7 |
| Interaction | SHOC2 interactions | 1.25e-04 | 74 | 132 | 5 | int:SHOC2 | |
| Interaction | MYH9 interactions | SEL1L VIM FNBP1 TTC16 ANXA1 ARFGEF1 MCM2 PARP14 PPP1CA SPDL1 PPP1CC EIF3A DNAH5 TRIM37 EP300 | 1.27e-04 | 754 | 132 | 15 | int:MYH9 |
| Interaction | KXD1 interactions | 1.31e-04 | 170 | 132 | 7 | int:KXD1 | |
| Interaction | PFN1 interactions | EVL DLG5 KTN1 MCM2 PPP1CA FZR1 RABEP1 SYNE2 KIF2A TRIM37 CEP97 CAP1 | 1.33e-04 | 509 | 132 | 12 | int:PFN1 |
| Interaction | LENG1 interactions | 1.33e-04 | 119 | 132 | 6 | int:LENG1 | |
| Interaction | KDM1A interactions | VIM DLG5 DSP POLR2B ZMYND8 MCM2 CHD7 KIF20B SEPTIN6 SPDL1 NCOR2 RABEP1 ASCC3 EP300 CSTF2T CUX1 NIN | 1.42e-04 | 941 | 132 | 17 | int:KDM1A |
| Interaction | MAPRE1 interactions | VIM DLG5 KTN1 PPP1CA SPDL1 IGSF10 MAP7D2 KIF2A EIF3A CEP97 EP300 NIN | 1.45e-04 | 514 | 132 | 12 | int:MAPRE1 |
| Interaction | MAK interactions | 1.48e-04 | 41 | 132 | 4 | int:MAK | |
| Interaction | ANPEP interactions | 1.51e-04 | 174 | 132 | 7 | int:ANPEP | |
| Interaction | POLR2B interactions | ILK POLR2B ZMYND8 POLR1C PIDD1 SPDL1 PPP1CC MED24 FZR1 SNRNP200 | 1.69e-04 | 371 | 132 | 10 | int:POLR2B |
| Interaction | CEBPA interactions | DDX19B FNBP1 EVL ILK ANXA1 IARS1 NAB2 ZMYND8 CHD7 SEPTIN6 PPP1CA MED24 NCOR2 EIF2S1 KIF2A SNRNP200 EP300 CSTF2T CUX1 CAP1 | 1.73e-04 | 1245 | 132 | 20 | int:CEBPA |
| Interaction | CUEDC2 interactions | 1.78e-04 | 43 | 132 | 4 | int:CUEDC2 | |
| Interaction | CIT interactions | VIM ILK DSP ANXA1 IARS1 POLR2B KTN1 ZMYND8 POLR1C TMOD2 PPP1CA PPP1CC ATAD3B DNAH12 EIF2S1 SYNE2 KIF2A EIF3A MMP15 SNRNP200 CUX1 NIN | 1.80e-04 | 1450 | 132 | 22 | int:CIT |
| Interaction | H3-4 interactions | VWF JADE3 PIDD1 MCM2 IPO4 SPDL1 KIF2A TRPM1 DNAH5 TRIM37 EP300 | 1.80e-04 | 448 | 132 | 11 | int:H3-4 |
| Interaction | BRCA1 interactions | ILK DSP ANXA1 IARS1 CARS1 ARFGEF1 MCM2 FANCM KIF20B BRAP PPP1CA PPP1CC MTOR EIF2S1 KIF2A EIF3A CABIN1 SNRNP200 EP300 CAP1 | 1.81e-04 | 1249 | 132 | 20 | int:BRCA1 |
| Interaction | HTRA4 interactions | 2.06e-04 | 183 | 132 | 7 | int:HTRA4 | |
| Interaction | CCNB1 interactions | 2.09e-04 | 244 | 132 | 8 | int:CCNB1 | |
| Interaction | TUBB4A interactions | 2.09e-04 | 244 | 132 | 8 | int:TUBB4A | |
| Interaction | AKT1 interactions | VIM ILK DSP ST14 PPP1CA PPP1CC NCOR2 FZR1 MTOR PKD1 APPL1 CARD11 EP300 | 2.10e-04 | 617 | 132 | 13 | int:AKT1 |
| Interaction | WDR76 interactions | 2.18e-04 | 383 | 132 | 10 | int:WDR76 | |
| Interaction | BTF3 interactions | VIM ILK DSP POLR2B CARS1 LAMB1 CHD7 PPP1CA ATAD3B MTOR EIF2S1 KIF2A ASCC3 SNRNP200 CUX1 | 2.38e-04 | 799 | 132 | 15 | int:BTF3 |
| Interaction | GSK3A interactions | DLG5 TTC16 LRSAM1 SNX29 PPP1CA PPP1CC RABEP1 EIF3A ASCC3 CEP97 NIN | 2.43e-04 | 464 | 132 | 11 | int:GSK3A |
| Interaction | DNAAF10 interactions | 2.45e-04 | 133 | 132 | 6 | int:DNAAF10 | |
| Interaction | PPP1R2C interactions | 2.53e-04 | 4 | 132 | 2 | int:PPP1R2C | |
| Interaction | PPP1R13L interactions | 2.83e-04 | 88 | 132 | 5 | int:PPP1R13L | |
| Interaction | NME1 interactions | 2.85e-04 | 193 | 132 | 7 | int:NME1 | |
| Interaction | KRT5 interactions | 2.85e-04 | 193 | 132 | 7 | int:KRT5 | |
| Interaction | CAMSAP3 interactions | 2.99e-04 | 138 | 132 | 6 | int:CAMSAP3 | |
| Interaction | YWHAH interactions | VIM DLG5 RIN3 DSP CEP85L SPEG MCM2 PABIR2 PPP1CA FZR1 MTOR STARD9 RABEP1 SYNE2 PLEKHA1 APPL1 KIF2A NIN | 3.09e-04 | 1102 | 132 | 18 | int:YWHAH |
| Interaction | DPYSL2 interactions | 3.09e-04 | 327 | 132 | 9 | int:DPYSL2 | |
| Interaction | STIP1 interactions | VIM ILK IARS1 POLR2B MCM2 IPO4 PPP1CC FZR1 MTOR EIF2S1 APPL1 KIF2A EIF3A ASCC3 SNRNP200 EP300 CAP1 | 3.11e-04 | 1006 | 132 | 17 | int:STIP1 |
| Interaction | CFH interactions | 3.23e-04 | 140 | 132 | 6 | int:CFH | |
| Interaction | RNF123 interactions | MYH4 DSP IARS1 KTN1 PIDD1 PARP14 PCDH17 RYR1 MIPOL1 IGSF10 PPP1R7 TRPM3 PKD1 EIF3A SNRNP200 | 3.30e-04 | 824 | 132 | 15 | int:RNF123 |
| Interaction | CEP126 interactions | 3.31e-04 | 91 | 132 | 5 | int:CEP126 | |
| Interaction | RASSF8 interactions | 3.31e-04 | 91 | 132 | 5 | int:RASSF8 | |
| Interaction | CPNE9 interactions | 3.35e-04 | 21 | 132 | 3 | int:CPNE9 | |
| Interaction | CLTC interactions | DDX19B VIM RIN3 ANXA1 IARS1 FBF1 MCM2 PPP1CA SPDL1 PPP1CC TRIM37 CEP97 EP300 | 3.73e-04 | 655 | 132 | 13 | int:CLTC |
| Interaction | EIF3B interactions | 3.85e-04 | 337 | 132 | 9 | int:EIF3B | |
| Interaction | BTBD10 interactions | 3.86e-04 | 22 | 132 | 3 | int:BTBD10 | |
| Interaction | RBBP4 interactions | FNBP1 DSP ZMYND8 MCM2 CHD7 IPO4 FZR1 APPL1 ASCC3 CABIN1 EP300 CUX1 | 3.92e-04 | 573 | 132 | 12 | int:RBBP4 |
| Interaction | LRRC31 interactions | 4.10e-04 | 205 | 132 | 7 | int:LRRC31 | |
| Interaction | CARMIL3 interactions | 4.20e-04 | 5 | 132 | 2 | int:CARMIL3 | |
| Interaction | ANKRD42 interactions | 4.20e-04 | 5 | 132 | 2 | int:ANKRD42 | |
| GeneFamily | X-linked mental retardation|RNA helicases | 2.47e-05 | 11 | 98 | 3 | 1168 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 1.94e-04 | 53 | 98 | 4 | 532 | |
| GeneFamily | CUT class homeoboxes and pseudogenes | 1.02e-03 | 9 | 98 | 2 | 527 | |
| GeneFamily | Laminin subunits | 1.85e-03 | 12 | 98 | 2 | 626 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 1.98e-03 | 46 | 98 | 3 | 622 | |
| GeneFamily | Protein phosphatase catalytic subunits|EF-hand domain containing | 2.18e-03 | 13 | 98 | 2 | 693 | |
| GeneFamily | Annexins|Endogenous ligands | 2.18e-03 | 13 | 98 | 2 | 404 | |
| GeneFamily | Dyneins, axonemal | 3.75e-03 | 17 | 98 | 2 | 536 | |
| GeneFamily | DNA helicases | 3.75e-03 | 17 | 98 | 2 | 1167 | |
| GeneFamily | Aminoacyl tRNA synthetases, Class I | 4.68e-03 | 19 | 98 | 2 | 131 | |
| GeneFamily | Zinc fingers MYND-type | 5.71e-03 | 21 | 98 | 2 | 87 | |
| GeneFamily | PWWP domain containing | 6.26e-03 | 22 | 98 | 2 | 1147 | |
| GeneFamily | Rho GTPase activating proteins|F-BAR domain containing | 6.83e-03 | 23 | 98 | 2 | 1288 | |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | VIM DLG5 PGS1 ILK CEP85L MCM2 CHD7 RNF114 PABIR2 SNX29 SPDL1 NCOR2 APPL1 EIF3A ASCC3 CEP97 CSTF2T CUX1 CAP1 | 8.52e-07 | 1009 | 133 | 19 | M157 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | FNBP1 IARS1 MATN2 KTN1 ARFGEF1 KIF20B SPDL1 RABEP1 SYNE2 APPL1 TRPM1 EIF3A EEA1 NIN | 6.52e-06 | 656 | 133 | 14 | M18979 |
| Coexpression | TRAVAGLINI_LUNG_CILIATED_CELL | CCDC146 DSP TTC16 ANXA1 ANXA4 SLC25A14 CARS1 EFHB PPP1R7 UBXN11 DNAH12 SYNE2 CIBAR2 MRPL40 KIF2A CABIN1 DNAH5 CEP97 | 1.08e-05 | 1093 | 133 | 18 | M41649 |
| Coexpression | ABE_VEGFA_TARGETS_30MIN | 1.36e-05 | 29 | 133 | 4 | M4078 | |
| Coexpression | GEORGES_CELL_CYCLE_MIR192_TARGETS | 1.60e-05 | 62 | 133 | 5 | M11038 | |
| Coexpression | GAO_ESOPHAGUS_25W_C1_CILIATED_EPITHELIAL_CELLS | TTC16 FRMPD2 EFHB SNX29 UBXN11 DNAH12 CIBAR2 ATP6V1C2 DNAH5 TRIM37 CEP97 | 2.34e-05 | 459 | 133 | 11 | M39136 |
| Coexpression | FLETCHER_PBMC_BCG_10W_INFANT_PPD_STIMULATED_VS_UNSTIMULATED_10W_DN | 3.99e-05 | 181 | 133 | 7 | M40912 | |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | FNBP1 DLG5 RIN3 HTRA1 IARS1 ANXA4 ZMYND8 ARFGEF1 CHD7 TMEM168 SYNE2 C2 MRPL40 CUX1 | 5.08e-05 | 790 | 133 | 14 | M12490 |
| Coexpression | GSE10325_BCELL_VS_MYELOID_UP | 6.82e-05 | 197 | 133 | 7 | M3081 | |
| Coexpression | GSE2405_0H_VS_12H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP | 7.26e-05 | 199 | 133 | 7 | M6197 | |
| Coexpression | GSE22589_HEALTHY_VS_SIV_INFECTED_DC_UP | 7.26e-05 | 199 | 133 | 7 | M7798 | |
| Coexpression | GSE21670_TGFB_VS_TGFB_AND_IL6_TREATED_CD4_TCELL_UP | 7.49e-05 | 200 | 133 | 7 | M7433 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | DSP SPEG KTN1 TMOD2 CHD7 SNX29 NCOR2 KLF10 RABEP1 SYNE2 APPL1 DNAH5 TRIM37 MXI1 NIN | 9.46e-05 | 946 | 133 | 15 | M39169 |
| Coexpression | MENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS | 9.70e-05 | 90 | 133 | 5 | M39250 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | DDX19B VIM ENOX1 CARMIL3 ANXA1 KTN1 SCRN1 CHD7 FANCM KIF20B PCDH17 RABEP1 SYNE2 MAP7D2 TRPM1 EIF3A CUX1 MXI1 PRODH | 1.20e-05 | 983 | 133 | 19 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | CEP85L IARS1 KTN1 CHD7 FANCM PABIR2 KIF20B SPDL1 PPP1R7 RABEP1 MAP7D2 EIF3A ASCC3 | 3.05e-05 | 532 | 133 | 13 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#2_top-relative-expression-ranked_200 | 3.82e-05 | 11 | 133 | 3 | gudmap_kidney_adult_RenalCapsule_k2_200 | |
| CoexpressionAtlas | dev gonad_e13.5_F_DevVascOvary_Flk_top-relative-expression-ranked_1000 | VIM RIN3 ANXA1 LAMA4 LAMB1 CHD7 NIBAN2 PABIR2 PCDH17 KLF10 STARD9 FES PLEKHA1 ARHGAP28 MMP15 NIN | 6.52e-05 | 831 | 133 | 16 | gudmap_dev gonad_e13.5_F_gudmap_devVascOvary_Flk_1000 |
| CoexpressionAtlas | kidney_adult_Mesangium_Meis_k-means-cluster#4_top-relative-expression-ranked_200 | 8.31e-05 | 14 | 133 | 3 | gudmap_kidney_adult_Mesangium_Meis_k4_200 | |
| CoexpressionAtlas | BM Top 100 - dorsal root ganglia | 8.36e-05 | 71 | 133 | 5 | BM Top 100 - dorsal root ganglia | |
| CoexpressionAtlas | BM Top 100 - trigeminal ganglia | 1.09e-04 | 75 | 133 | 5 | BM Top 100 - trigeminal ganglia | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.63e-04 | 246 | 133 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K3 | |
| CoexpressionAtlas | kidney_adult_Mesangium_Meis_k-means-cluster#1_top-relative-expression-ranked_500 | 1.80e-04 | 45 | 133 | 4 | gudmap_kidney_adult_Mesangium_Meis_k1_500 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Mesenchymal-BMP_responsible_cell|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 1.61e-07 | 200 | 133 | 8 | 26251ed8c7fa7e87973d6f59bd398c88ad025395 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal|6m / Sample Type, Dataset, Time_group, and Cell type. | 1.61e-07 | 200 | 133 | 8 | 13ec8afea86e4a10599c924871ba4e325b0a8013 | |
| ToppCell | droplet-Kidney-nan-3m-Lymphocytic-lymphocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.39e-07 | 160 | 133 | 7 | 5c28121916a12dbc22ef2421040bdc9148a40b78 | |
| ToppCell | droplet-Kidney-nan-3m-Lymphocytic-CD45|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.39e-07 | 160 | 133 | 7 | b7093678987575f2f99d648821d31b4a37075aca | |
| ToppCell | normal-na-Lymphocytic_T-T4_em-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 8.43e-07 | 171 | 133 | 7 | 61318a7aaf3bd8bdd28f8a8614ab4fdf2964b3a3 | |
| ToppCell | droplet-Kidney-nan-21m-Lymphocytic-lymphocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.43e-07 | 171 | 133 | 7 | 0385d5834ae16bbb0c6a68893fec60e4dd1e478d | |
| ToppCell | droplet-Kidney-nan-21m-Lymphocytic-CD45|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.43e-07 | 171 | 133 | 7 | a3e3fe0cbab21abb178c482f5951e576529f7e30 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Endothelial_cells-Tumor_ECs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 1.53e-06 | 187 | 133 | 7 | be5f8c5802b0fa8cc1e274fdf06b13eb8ceb8ad4 | |
| ToppCell | moderate-Epithelial-Ciliated-diff|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.76e-06 | 191 | 133 | 7 | 6cdc6a0c0a1ce5a1ef550832319847f62e718975 | |
| ToppCell | 10x5'v1-week_12-13-Endothelial-stroma-tip_EC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.76e-06 | 191 | 133 | 7 | cf1a67b7c0d5c0dc5d4d59faf9d9b1a3a1fb00e0 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.83e-06 | 192 | 133 | 7 | 1b228f0929b505de82a39bf64c837887b0e56701 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Mesenchymal-mesenchymal_stem_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-06 | 193 | 133 | 7 | 160691b671710be10220803d788c2c961c236af1 | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.96e-06 | 194 | 133 | 7 | 7826fe5eb254ac032de0d978f39585a40e0b3ee4 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.96e-06 | 194 | 133 | 7 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | 10x5'v1-week_17-19-Endothelial|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.96e-06 | 194 | 133 | 7 | e141beafc9252e5d8c949252bfab53e127c881dc | |
| ToppCell | 10x5'v1-week_17-19-Endothelial-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.96e-06 | 194 | 133 | 7 | 953578102ffc7b612ee8fce45e414750800fef5d | |
| ToppCell | 10x5'v1-week_17-19-Endothelial-stroma-sinusoidal_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.02e-06 | 195 | 133 | 7 | 22a481927147ec4ae9d59e6af7c87df0e9cb51e4 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.02e-06 | 195 | 133 | 7 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.02e-06 | 195 | 133 | 7 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.09e-06 | 196 | 133 | 7 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | Bronchial_Brush-Epithelial|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.17e-06 | 197 | 133 | 7 | 272c7f4e582ef57564450540242b0db766b78328 | |
| ToppCell | control-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.17e-06 | 197 | 133 | 7 | e453d085182364ca347cbcc9dc995c62c3353016 | |
| ToppCell | Tracheal-NucSeq-Stromal-Schwann|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.17e-06 | 197 | 133 | 7 | c1b2a3fbd5f4aeb3555d8c372efc86f1052e7c65 | |
| ToppCell | control-Epithelial-Ciliated|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.17e-06 | 197 | 133 | 7 | d4e963c1f82996371bf3d63578ee9fce8e00c5a8 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.17e-06 | 197 | 133 | 7 | 13896ec65ccda0b928c91d41112dc01b480036b7 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 2.24e-06 | 198 | 133 | 7 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-1m-Mesenchymal-Cilia-bearing_cell|1m / Sample Type, Dataset, Time_group, and Cell type. | 2.32e-06 | 199 | 133 | 7 | fd91fdc76decd5876d5e914d68134282aba9c4c8 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.39e-06 | 200 | 133 | 7 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 2.39e-06 | 200 | 133 | 7 | 5ba4ed490c64b3bb738e7729669f893fa73aa56f | |
| ToppCell | normal_Lung-Fibroblasts|normal_Lung / Location, Cell class and cell subclass | 2.39e-06 | 200 | 133 | 7 | 803cf7f1382d07220249029cd220233232027689 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Mesenchymal|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 2.39e-06 | 200 | 133 | 7 | fe22f7c97f4e37dfa7881d0f1d9245c1237d873b | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.39e-06 | 200 | 133 | 7 | cbf6a6c3db88bac37bd084a3a914b12b3af524eb | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.39e-06 | 200 | 133 | 7 | ddd39b754bfaa98249d497dfb7e97ec58617a11a | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Mesenchymal-BMP_responsible_cell|3m / Sample Type, Dataset, Time_group, and Cell type. | 2.39e-06 | 200 | 133 | 7 | a4b52466b6426a835655b5fe7487e15aea816e14 | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-Ciliated|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 2.39e-06 | 200 | 133 | 7 | a521cf837cadf280505ff9d7e641a205af7d6513 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.39e-06 | 200 | 133 | 7 | 918b576fd9491d23c2bb9d663fa5fb3505cb1c7e | |
| ToppCell | Parenchymal-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.39e-06 | 200 | 133 | 7 | 4c3c11dd5e71ebc3d62264eeaeb71a850b149779 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.99e-06 | 154 | 133 | 6 | 4e3bc24043144143842627cacf6f90dda2228910 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.99e-06 | 154 | 133 | 6 | 7556a4b2b062da5ae7ec2bbb66e745e7662db628 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.25e-06 | 155 | 133 | 6 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.25e-06 | 155 | 133 | 6 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | 15-Distal-Epithelial-Multiciliated_cell|Distal / Age, Tissue, Lineage and Cell class | 1.19e-05 | 169 | 133 | 6 | 425d89ab69e9f9eb3df84056676423e390cc6ab1 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l48|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.23e-05 | 170 | 133 | 6 | 070d8683d1a5cc7d594ff0453c961a9bf982c2d0 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-lymphocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-05 | 172 | 133 | 6 | e680abead2da75e50774da02384eb2729c839c01 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_ciliated|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.45e-05 | 175 | 133 | 6 | b1369d2b74f461e6822d0c33e9b50fe0dfbceb54 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.45e-05 | 175 | 133 | 6 | c82ec6deb6ccdd991a69a62b6d62d5b14c803d7a | |
| ToppCell | Ciliated_cells-B-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.54e-05 | 177 | 133 | 6 | c38138fb5ad9766c2d240811210c854338cd612e | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L2-4_RORB_GRIK1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.59e-05 | 178 | 133 | 6 | 674ee5095b98929c29e4f6bd56029a336cc4a38c | |
| ToppCell | BAL-Mild-cDC_4|Mild / Compartment, Disease Groups and Clusters | 1.65e-05 | 179 | 133 | 6 | 68511e87b12b8253de7771e5ccfc5869248b8450 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Endothelial_cells|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 1.81e-05 | 182 | 133 | 6 | d7cce5dd7046f06bf40f00c9dbfa610722b03333 | |
| ToppCell | pdx-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.81e-05 | 182 | 133 | 6 | 7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.86e-05 | 183 | 133 | 6 | b1336eac5adbffade4cef3e0ce3de75a781ae365 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.86e-05 | 183 | 133 | 6 | cc57dcb59c68d68a546dc108dd9e009b2aab8da5 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-05 | 183 | 133 | 6 | 8330c39184ce076e1f95fd3725b68af551d89db0 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.92e-05 | 184 | 133 | 6 | 4d4d8f3f44c67d74c57e7af7b7c158f0157b2f49 | |
| ToppCell | Ciliated_cells-B-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.98e-05 | 185 | 133 | 6 | f012c243343e1d1956db19b34d062e9b13de2b2a | |
| ToppCell | Ciliated_cells-A-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 1.98e-05 | 185 | 133 | 6 | d77ca57b02125a3a57a37f4aed20c89803b7d551 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.04e-05 | 186 | 133 | 6 | 6f88b68735d0f7c9904eb8413e6007910d556185 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.04e-05 | 186 | 133 | 6 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.11e-05 | 187 | 133 | 6 | 6f47a80e612b320f571210483e62ff5db2a8ea43 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.11e-05 | 187 | 133 | 6 | 8bd635abdee5d5a12a3f7bf74eab4282e8e40741 | |
| ToppCell | Ciliated_cells-B-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 2.11e-05 | 187 | 133 | 6 | bc1f33f332ac939c2425f510173430ca2ba0c3ee | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.11e-05 | 187 | 133 | 6 | 3cb8cd7f7a4306ff74d1f7f9964014008ec1c6a0 | |
| ToppCell | Ciliated_cells-B-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 2.17e-05 | 188 | 133 | 6 | 606907c865bd2f11bb6474932716550f7723d858 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-05 | 189 | 133 | 6 | 1821ae4a6e37ee4c6308071883f3f447a7c53c53 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-05 | 189 | 133 | 6 | 1e4d7e8dc98b3d70351e6a6c2aaf9ca01f141b8f | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-05 | 189 | 133 | 6 | 1dc415ed41815f4296dafd8cf7f3e014c44db1db | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.30e-05 | 190 | 133 | 6 | 9ce7df056bfb24d70db4c3c4a2c57d89115de877 | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.30e-05 | 190 | 133 | 6 | 833481ace2800354712e2ce709d5cdfd0aed3d42 | |
| ToppCell | Ciliated_cells-B|World / lung cells shred on cell class, cell subclass, sample id | 2.30e-05 | 190 | 133 | 6 | 7031fbedc13be1a00f6333ad6d51849c3739c2e6 | |
| ToppCell | Control-T_cells-CD4+_T_cells|Control / group, cell type (main and fine annotations) | 2.30e-05 | 190 | 133 | 6 | 0733be5e54fe15d6d6ea51c154a95258e83f1b92 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_DC-DC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.30e-05 | 190 | 133 | 6 | d06800ec9f6065c1cc536ed99e8569732272a94f | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.30e-05 | 190 | 133 | 6 | 96a92212ea3fb35fa3d0da495e504edc61c71c23 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_DC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.30e-05 | 190 | 133 | 6 | 485073e831afebdb393c7f4b622504d43d1b778b | |
| ToppCell | Adult-Immune-T_lymphocyte-D175|Adult / Lineage, Cell type, age group and donor | 2.37e-05 | 191 | 133 | 6 | 0b84fd1dc68146d9f72422b102744d2847f5ecb2 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated-diff|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.37e-05 | 191 | 133 | 6 | 3e84c453e8a151c42808fe2935f1d732e180008c | |
| ToppCell | moderate-Epithelial-Ciliated-diff|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.37e-05 | 191 | 133 | 6 | b1bb27aab6ec651b45d5eea0a6b61a1da0fc6204 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.37e-05 | 191 | 133 | 6 | e81cd65dbf0ef1c2ab7088f73ce605d456dd3a7a | |
| ToppCell | COVID-19-T_cells-CD4+_T_cells|COVID-19 / group, cell type (main and fine annotations) | 2.37e-05 | 191 | 133 | 6 | 0646cca78e24aeb6baa9934d3c439b797c567997 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-05 | 192 | 133 | 6 | a2c31390da4962bda9a936470b0b68fa1f5d47d1 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.44e-05 | 192 | 133 | 6 | be592e661367affced9ebe80849b466e6adb3a34 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.44e-05 | 192 | 133 | 6 | 29bee88b45e23f16543ffc7cc361bc5da5d16a2b | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-05 | 192 | 133 | 6 | eeab1cef7c36ae824381952c5b2c982368c379fd | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-05 | 192 | 133 | 6 | beac6b3c191b11add8e39e8d04562b478ea8929e | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.44e-05 | 192 | 133 | 6 | 32acd89617934016cd135d2cc797e8e79ae1b37f | |
| ToppCell | multiciliated|World / shred by cell class for turbinate | 2.44e-05 | 192 | 133 | 6 | 0f89ea0deb651ca11531c51ee94e0233608d22ea | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.44e-05 | 192 | 133 | 6 | cdc652dbfabe41b324fd85c1ed933d29fb73a49f | |
| ToppCell | Bronchial_Brush|World / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.52e-05 | 193 | 133 | 6 | 3e693ac4c92576e3f2c9efdd3f1d96d3d336e260 | |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 2.52e-05 | 193 | 133 | 6 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.52e-05 | 193 | 133 | 6 | 9d0b966d13cbce97beb43de6dc77f006c363a181 | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Scara5+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-05 | 193 | 133 | 6 | 80380358f44c2f4781676ec0f1fa94d4c69080d6 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.52e-05 | 193 | 133 | 6 | d5930f7bd9b299f792212d40a3272a37adf64a82 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.52e-05 | 193 | 133 | 6 | fe9720185929ef849edd1b8eb4854306b392e5a2 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.52e-05 | 193 | 133 | 6 | 0b62a6ddd7c42efd9f39781971d1438501e1fa8d | |
| ToppCell | Adult-Immune-T_lymphocyte|Adult / Lineage, Cell type, age group and donor | 2.52e-05 | 193 | 133 | 6 | 26df0c4c8a2355dd5503fadd07e368eb9a2bf06a | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.52e-05 | 193 | 133 | 6 | b9769b45125d2244afe53f9f71c92c04ddccf980 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.59e-05 | 194 | 133 | 6 | 756082a0f5953b52229bb60d40b84701cb6cb23d | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.59e-05 | 194 | 133 | 6 | 3cd90d01ed5a5ce65aad8284dab2537ec16e3d7c | |
| ToppCell | critical-Epithelial-Ciliated-diff|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.59e-05 | 194 | 133 | 6 | 176090949b53c043c58df63ad8cf4f486b350bdc | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_1|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.59e-05 | 194 | 133 | 6 | b4ce60c06568123008b1081d644733cb91c28f51 | |
| Drug | Betonicine [515-25-3]; Down 200; 25.2uM; PC3; HT_HG-U133A | 2.55e-06 | 198 | 133 | 9 | 3745_DN | |
| Drug | monomethyl phthalate | VIM MYH4 ABCC4 PGS1 HTRA1 DSP LAMA4 CHD7 RNF114 ST14 PPP1CA NCOR2 FZR1 RABEP1 EIF3A EEA1 CABIN1 MMP15 CUX1 | 3.06e-06 | 957 | 133 | 19 | ctd:C517284 |
| Disease | Sarcomatoid Renal Cell Carcinoma | 2.28e-05 | 128 | 130 | 6 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 2.28e-05 | 128 | 130 | 6 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 2.28e-05 | 128 | 130 | 6 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 2.28e-05 | 128 | 130 | 6 | C1306837 | |
| Disease | Renal Cell Carcinoma | 2.28e-05 | 128 | 130 | 6 | C0007134 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 5.14e-05 | 148 | 130 | 6 | C0279702 | |
| Disease | malignant hyperthermia (is_implicated_in) | 5.76e-05 | 3 | 130 | 2 | DOID:8545 (is_implicated_in) | |
| Disease | unipolar depression, bipolar disorder | 6.89e-05 | 156 | 130 | 6 | EFO_0003761, MONDO_0004985 | |
| Disease | Myopathy, Centronuclear, Autosomal Recessive | 1.15e-04 | 4 | 130 | 2 | C0410204 | |
| Disease | autosomal dominant polycystic kidney disease (is_implicated_in) | 1.15e-04 | 4 | 130 | 2 | DOID:898 (is_implicated_in) | |
| Disease | motor function measurement, response to levodopa | 1.15e-04 | 4 | 130 | 2 | EFO_0010747, EFO_0010749 | |
| Disease | age-related macular degeneration, COVID-19 | 2.49e-04 | 69 | 130 | 4 | EFO_0001365, MONDO_0100096 | |
| Disease | pleckstrin homology domain-containing family A member 1 measurement | 3.99e-04 | 7 | 130 | 2 | EFO_0802873 | |
| Disease | MASA syndrome (implicated_via_orthology) | 3.99e-04 | 7 | 130 | 2 | DOID:0060246 (implicated_via_orthology) | |
| Disease | Autistic behavior | 5.30e-04 | 8 | 130 | 2 | C0856975 | |
| Disease | Liver Cirrhosis, Experimental | 6.49e-04 | 774 | 130 | 11 | C0023893 | |
| Disease | age-related macular degeneration | 6.58e-04 | 89 | 130 | 4 | EFO_0001365 | |
| Disease | insomnia measurement | 7.99e-04 | 443 | 130 | 8 | EFO_0007876 | |
| Disease | cerebral infarction (biomarker_via_orthology) | 8.47e-04 | 10 | 130 | 2 | DOID:3526 (biomarker_via_orthology) | |
| Disease | immunoglobulin isotype switching measurement | 9.70e-04 | 44 | 130 | 3 | EFO_0010128 | |
| Disease | migraine disorder | 1.06e-03 | 357 | 130 | 7 | MONDO_0005277 | |
| Disease | Colorectal Carcinoma | EVL ABCC4 FRMPD2 ARFGEF1 KCNB2 ABCA9 PTPRS SNRNP200 EP300 CUX1 | 1.12e-03 | 702 | 130 | 10 | C0009402 |
| Disease | Night blindness, congenital stationary, type 1 | 1.24e-03 | 12 | 130 | 2 | C3501847 | |
| Disease | Night Blindness, Congenital Stationary, Type 1A | 1.24e-03 | 12 | 130 | 2 | C3495587 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B (disorder) | 1.24e-03 | 12 | 130 | 2 | C1864877 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B | 1.24e-03 | 12 | 130 | 2 | C1850362 | |
| Disease | X-Linked Csnb | 1.24e-03 | 12 | 130 | 2 | C3711543 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A | 1.24e-03 | 12 | 130 | 2 | C1848172 | |
| Disease | coffee consumption measurement | 1.30e-03 | 182 | 130 | 5 | EFO_0006781 | |
| Disease | atrial fibrillation | 1.32e-03 | 371 | 130 | 7 | EFO_0000275 | |
| Disease | hematologic cancer (implicated_via_orthology) | 1.46e-03 | 13 | 130 | 2 | DOID:2531 (implicated_via_orthology) | |
| Disease | Cone-rod synaptic disorder, congenital nonprogressive | 1.46e-03 | 13 | 130 | 2 | C4041558 | |
| Disease | immature platelet fraction | 1.65e-03 | 114 | 130 | 4 | EFO_0009187 | |
| Disease | Prostatic Neoplasms | 1.67e-03 | 616 | 130 | 9 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 1.67e-03 | 616 | 130 | 9 | C0376358 | |
| Disease | Malformations of Cortical Development | 1.69e-03 | 14 | 130 | 2 | C1955869 | |
| Disease | chromosome 22q11.2 deletion syndrome, distal (implicated_via_orthology) | 1.69e-03 | 14 | 130 | 2 | DOID:0060413 (implicated_via_orthology) | |
| Disease | Cortical Dysplasia | 1.69e-03 | 14 | 130 | 2 | C0431380 | |
| Disease | Autosomal Recessive Centronuclear Myopathy | 1.95e-03 | 15 | 130 | 2 | C3645536 | |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 2.22e-03 | 16 | 130 | 2 | DOID:0110861 (implicated_via_orthology) | |
| Disease | sphingomyelin 14:0 measurement | 2.51e-03 | 17 | 130 | 2 | EFO_0010390 | |
| Disease | Night blindness, congenital stationary | 2.51e-03 | 17 | 130 | 2 | C0339535 | |
| Disease | level of Sphingomyelin (d32:1) in blood serum | 2.51e-03 | 17 | 130 | 2 | OBA_2045173 | |
| Disease | Age-related macular degeneration | 2.81e-03 | 18 | 130 | 2 | cv:C0242383 | |
| Disease | Malignant neoplasm of breast | VIM EVL VWF CEP85L KTN1 MTOR SYNE2 MAP7D2 APPL1 EP300 CUX1 PRODH | 2.86e-03 | 1074 | 130 | 12 | C0006142 |
| Disease | Microcephaly | 3.26e-03 | 67 | 130 | 3 | C0025958 | |
| Disease | mitochondrial DNA measurement | 3.40e-03 | 328 | 130 | 6 | EFO_0006312 | |
| Disease | coagulation factor measurement | 3.47e-03 | 20 | 130 | 2 | EFO_0004634 | |
| Disease | osteoarthritis, hip, osteoarthritis, knee, total joint arthroplasty | 3.83e-03 | 21 | 130 | 2 | EFO_0004616, EFO_0010726, EFO_1000786 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VEMAMQIQRAAETQR | 1926 | Q09472 | |
| RREMTDVIIETMKSN | 66 | Q7Z569 | |
| MNIVFSRDSQVRVME | 1 | Q6ZTR7 | |
| MIMTDLERANQRAEV | 231 | P39880 | |
| GEEEDIQMERMRTVN | 1256 | Q8IUA7 | |
| MRTVNAMAVRDFDET | 1266 | Q8IUA7 | |
| TIRDMVVRCIAQMVN | 1251 | Q9Y6D6 | |
| ERSREMQMIDLQTGT | 116 | Q9Y276 | |
| RVREVESTPMIMENI | 271 | Q8NEB7 | |
| MADMQNLVERLERAV | 1 | Q01518 | |
| NTLIRVMVSRAEIDM | 266 | P09525 | |
| SRMRREMLVEGTQDE | 1221 | O14529 | |
| ERHQERRTQMETEMG | 76 | Q9H7B7 | |
| MEMVAQLRESQVVSE | 2421 | Q9P2D1 | |
| TELMNSVMVRTEEEI | 641 | Q9Y222 | |
| EVMRQSVKRMIDSED | 156 | Q06432 | |
| DIMLVQSEVEERNAM | 766 | O14917 | |
| RDMQRMEIVLTSEQL | 296 | Q15276 | |
| EQMAVLMQSREQVSE | 626 | Q15276 | |
| MQAVIRTDMDQIITS | 301 | Q96TA1 | |
| VIEDDVNMAIRVMLE | 786 | P49736 | |
| LIRIMVSRSEIDMND | 296 | P04083 | |
| EEEKMRMEVVNRIES | 136 | Q8NDF8 | |
| ELIQNMDRVDREITM | 171 | Q9Y618 | |
| MDRVDREITMVEQQI | 176 | Q9Y618 | |
| TQRLEEMTQRMEALE | 936 | O00339 | |
| REVAEQMRLEREQIM | 516 | Q96T17 | |
| MRITAEEMSALIEER | 256 | Q8TD10 | |
| NERIRMEQLMSITQE | 361 | Q6UWE0 | |
| MVRMVVESVERIFRS | 241 | Q15742 | |
| VEDVVMVNVRSIAEM | 16 | P05198 | |
| MSVLNDNSRDMTEVI | 306 | P06681 | |
| QMEEVARTVNVVMVL | 616 | P51511 | |
| VRREMDSDIETMQQT | 236 | Q9UKG1 | |
| MVVERRSQSEMLNSV | 1861 | Q8IYD8 | |
| NQILVETERGMVSMR | 81 | Q8ND23 | |
| RVMDVINSARTRQQM | 306 | Q32NB8 | |
| ELVQDMQESINMERV | 61 | P35913 | |
| PDEMDIQRRQVMEQH | 131 | Q9UI08 | |
| DMRMTLEEQEQTQVE | 1376 | Q96Q89 | |
| VMDQEFSRRLSMSEV | 1656 | Q8TDM6 | |
| EESMNTVLVQEMERF | 2846 | Q6ZR08 | |
| VEQSALMRDRVEDVM | 1346 | P07942 | |
| EMMTEKERSNVVITR | 361 | Q86UP2 | |
| EQRSATIVMMTRLEE | 1481 | Q13332 | |
| VNRETAHEREMQTAM | 66 | Q7Z309 | |
| AEVENMMISVERVIE | 1001 | O15439 | |
| QSMEQIRRIMRPTDV | 181 | P62136 | |
| SRDVMQARDEIEAMI | 1501 | Q460N5 | |
| QMVEMEEQVVEDHRA | 616 | O00139 | |
| QNENTMPRVTEMRRT | 16 | Q9UM11 | |
| VQVQTLMDNMTLERE | 231 | Q15075 | |
| VTAQQMAMERAELER | 846 | Q8TES7 | |
| ERRVVMLTMEERVTS | 1926 | Q6WRI0 | |
| STLNMVVRRGNEDIM | 456 | Q92743 | |
| EQMNEELRREAETMR | 146 | Q92953 | |
| ELVQQMEGRRDSMLE | 1171 | Q9Y6J0 | |
| TQDEMQRMSTRVLLA | 311 | Q14152 | |
| IQEMEERRIVRMGES | 216 | Q96RU3 | |
| ENSVQMMRSEINTEV | 461 | Q8IW35 | |
| RMTALRVQVEVSEMH | 506 | Q68DX3 | |
| DQMEILDSLIREMRQ | 116 | P15924 | |
| EMMVEQRAAVIERFR | 366 | Q9UMR2 | |
| NSRSVMIDEDMTARI | 321 | Q13418 | |
| QQDEIDRMILEIQSM | 626 | Q5SZL2 | |
| EMGLERQNISRTVMQ | 71 | Q8N7U6 | |
| ASLQQTAEERMEMIS | 6 | Q13118 | |
| RAMETRAMETEVLET | 416 | Q9H0L4 | |
| RAMETEVLETRVMER | 421 | Q9H0L4 | |
| LEEFNVLEMEVMRRQ | 126 | Q969F0 | |
| MMVEQRAAVIERFRE | 366 | Q9NUU7 | |
| ELTMAEMRQSLEQER | 986 | Q9ULU4 | |
| QSQEMMEVDRRVESE | 11 | Q15435 | |
| RQMVDMLVESSSNVE | 4041 | P21817 | |
| AQSEQLMGIRREEEM | 386 | Q8TC92 | |
| MQAVNRERERQVVMA | 756 | Q8TEX9 | |
| EMRIEMVRREACIVN | 416 | Q9BXL7 | |
| IRNMQVPQESLEMRT | 576 | Q92613 | |
| TESTIVMRVLRDMNL | 2176 | Q8TE73 | |
| VSMQVVRMAGRELQA | 491 | Q9HB75 | |
| VTVERMNRMQGLQVS | 1011 | P98161 | |
| MARQTSSTEMLQEIR | 631 | Q8TB24 | |
| ERVREQMEVVNMSLS | 521 | Q16363 | |
| QKAEREVSRMVVVMV | 241 | P03999 | |
| VQQAMMVSEELIRVA | 2006 | P42345 | |
| ELAVATEMVFRRQEM | 316 | P07332 | |
| TEMVFRRQEMVTQLQ | 321 | P07332 | |
| SLIRRMAQSVVEVME | 66 | Q8NEY4 | |
| MERDTIRAMLEAQQE | 131 | Q9NQ50 | |
| RREDMASVLEMSVQF | 86 | Q5JUK2 | |
| DERVREIRNAVEMMI | 176 | O94972 | |
| EIRNAVEMMIARLDT | 181 | O94972 | |
| TISELRQATVAMMNR | 466 | Q8TEQ0 | |
| TRTVMEEMRALVSQC | 511 | P49589 | |
| ERERELQMTLNTRME | 1201 | Q8WXH0 | |
| IRETNIRDMFTQLDM | 721 | Q9UBV2 | |
| QLVTVMEERMIEVEQ | 2031 | Q8N4C6 | |
| ERVVIMNSILERMCA | 661 | O75448 | |
| RVQTEMELRMFRQNE | 441 | Q8NB12 | |
| SRFTEEEELQMTRML | 346 | O43272 | |
| EELRVMSERVQESMS | 146 | Q96EA4 | |
| RRQMDIIVSEVSMIR | 591 | P30876 | |
| AMVERRANLMQAEVE | 1676 | Q9Y623 | |
| MVDEGMAREVINRIQ | 981 | P41252 | |
| MAASQAVEEMRSRVV | 1 | O15160 | |
| EELTETQHMIQRRIM | 816 | Q15477 | |
| VNNTDEMARLIRSVM | 2041 | Q9P2P6 | |
| EMLIRVNMEDLREQT | 276 | Q14141 | |
| EESITVQTMMNTLRD | 246 | Q12765 | |
| RLANTITMIEEEMVQ | 611 | Q8IYE0 | |
| QEAMRRATVEREMEL | 166 | Q5T9A4 | |
| MDEREMENIIATVRD | 1591 | Q8N3C0 | |
| QVPSEMTEDIMRDRI | 126 | Q7Z5L4 | |
| VDVVRTRMMNQRAIV | 256 | O95258 | |
| LMDSETDMVRQIRAL | 86 | Q9UID3 | |
| MMAQEAEQISIQERV | 406 | Q9H0M4 | |
| MEEVIQRMDVGQDSI | 1521 | P04275 | |
| GRSVTEMEVMQFLNR | 1001 | Q99973 | |
| MDQSVREGQDVIMSI | 876 | Q15772 | |
| VDEEDMMNQVLQRSI | 211 | Q9Y508 | |
| QRRLDVMEEMVEKTV | 46 | Q5JTB6 | |
| VMLMVNSLTERDVRF | 166 | A6NFA1 | |
| ERIRVTSERVENMSM | 1241 | Q9HCF6 | |
| TSERVENMSMRLEEV | 1246 | Q9HCF6 | |
| ENMSMRLEEVNEREH | 1251 | Q9HCF6 | |
| SFLITQVRRMNEATM | 581 | Q9P2N2 | |
| VEEAERVMAEERVVM | 166 | Q9Y5Y6 | |
| ERQMREMEENFAVEA | 341 | P08670 | |
| AMTRLEEVNREVNMH | 16 | Q9H0V1 | |
| QSMEQIRRIMRPTDV | 181 | P36873 | |
| LVQEIESVSTQMRRM | 351 | Q96SK2 | |
| SERVENMSMRLEEIN | 1186 | Q7Z4N2 | |
| RVRQSRMDTDLETMD | 381 | O75643 | |
| MVSNMTEERANVIAT | 311 | P36537 | |
| EEEDRMLTQLVQEMR | 351 | Q5SXM2 | |
| MRENVVVSNMERESG | 1 | Q53H54 | |
| VLDMVTEDQEDMVRQ | 311 | Q8NEE8 | |
| QSLVQDMDSMVRLMR | 466 | Q8NHP8 | |
| IMMRDNLFEIVTTSR | 251 | Q9HB21 | |
| EMEIAQMLEENSRIL | 301 | Q9NZR1 | |
| TMCVQLQRQVREMER | 131 | Q5T124 | |
| QEMERIRMDSIGSTI | 151 | P50539 |